Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOVO
526
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $110M | 0.02% |
5,638,956
-570,586
| -9% | -$10.3M |
|
527
Synaptics
SYNA
$4.13B
| $110M | 0.02% |
1,289,859
-1,373,043
| -52% | -$119M |
|
528
VanEck Gold Miners ETF
GDX
$23.2B
| $109M | 0.02% |
3,635,331
+1,019,437
| +39% | +$33.2M |
|
529
Primoris Services
PRIM
$4.77B
| $109M | 0.02% |
3,582,603
-197,936
| -5% | -$5.3M |
|
530
iShares MSCI ACWI ex US ETF
ACWX
$11.6B
| $109M | 0.02% |
2,209,993
-139,101
| -6% | -$6.85M |
|
|
ITCI
531
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $108M | 0.02% |
1,701,584
-3,323,199
| -66% | -$207M |
|
532
Intellia Therapeutics
NTLA
$1.5B
| $107M | 0.02% |
2,615,364
-350,776
| -12% | -$14.2M |
|
533
Scotiabank
BNS
$108B
| $106M | 0.02% |
2,124,722
-1,859,075
| -47% | -$92.2M |
|
534
Southwest Airlines
LUV
$23B
| $105M | 0.02% |
2,896,413
-754,381
| -21% | -$23.7M |
|
535
Seadrill
SDRL
$2.66B
| $104M | 0.02% |
2,510,150
+1,980,677
| +374% | +$73.6M |
|
536
Verisk Analytics
VRSK
$25.1B
| $103M | 0.02% |
454,520
-209,642
| -32% | -$44M |
|
537
Apollo Global Management
APO
$74.6B
| $102M | 0.02% |
1,331,472
-3,542,156
| -73% | -$237M |
|
538
Gentex
GNTX
$4.99B
| $102M | 0.02% |
3,492,520
+104,661
| +3% | +$2.88M |
|
539
Rocket Pharmaceuticals
RCKT
$372M
| $102M | 0.02% |
5,142,457
+1,034,529
| +25% | +$20.9M |
|
540
Cameco
CCJ
$39.1B
| $102M | 0.02% |
3,258,841
-223,652
| -6% | -$6.29M |
|
541
Hubbell
HUBB
$25.2B
| $102M | 0.02% |
308,153
+17,408
| +6% | +$4.82M |
|
542
DraftKings
DKNG
$11.7B
| $102M | 0.02% |
3,836,174
-4,420,231
| -54% | -$102M |
|
543
Onto Innovation
ONTO
$13.4B
| $102M | 0.02% |
873,352
+409,513
| +88% | +$39.1M |
|
544
Applied Industrial Technologies
AIT
$13B
| $101M | 0.02% |
697,539
-174,949
| -20% | -$23.3M |
|
545
SouthState Bank Corp
SSB
$10.5B
| $100M | 0.02% |
1,525,859
-3,437
| -0.2% | -$229K |
|
|
STER
546
DELISTED
Sterling Check Corp. Common Stock
STER
| $100M | 0.02% |
8,174,089
+2,297,637
| +39% | +$27.5M |
|
547
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $100M | 0.02% |
2,030,749
+312,420
| +18% | +$15.3M |
|
548
Amphenol
APH
$201B
| $98.5M | 0.02% |
2,319,668
-27,712
| -1% | -$1.08M |
|
|
SQSP
549
DELISTED
Squarespace, Inc.
SQSP
| $98.4M | 0.02% |
3,121,269
-48,119
| -2% | -$1.45M |
|
550
Aptiv
APTV
$12.1B
| $98.4M | 0.02% |
963,947
-325,598
| -25% | -$32.2M |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.